Lazaros I Sakkas Selected Research

Systemic Lupus Erythematosus (Libman-Sacks Disease)

10/2020	A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies.
1/2018	Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.
1/2017	Phosphodiesterase 4 Inhibitors in Immune-mediated Diseases: Mode of Action, Clinical Applications, Current and Future Perspectives.
4/2016	Tuberculous pyomyositis: a re-emerging entity of many faces.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lazaros I Sakkas Research Topics

Disease

22	Systemic Scleroderma (Systemic Sclerosis) 03/2024 - 04/2002
14	Rheumatoid Arthritis 07/2022 - 04/2007
9	Fibrosis (Cirrhosis) 01/2023 - 04/2002
9	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2013
9	Psoriatic Arthritis 01/2022 - 01/2013
7	Rheumatic Diseases (Rheumatism) 03/2020 - 04/2007
6	Multiple Sclerosis 01/2021 - 01/2016
6	Arthritis (Polyarthritis) 09/2019 - 11/2014
5	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 01/2013
4	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2024 - 10/2010
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2020 - 04/2016
3	Inflammation (Inflammations) 09/2022 - 01/2013
3	Fever (Fevers) 09/2019 - 01/2008
3	Infections 12/2016 - 01/2008
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 01/2017
2	Periodontitis 07/2018 - 11/2014
2	Pathologic Constriction (Stenosis) 02/2016 - 12/2006
1	digital ulcers 03/2024
1	Hypogonadism (Hypergonadotropic Hypogonadism) 09/2022
1	Necrosis 09/2022
1	Ovarian Neoplasms (Ovarian Cancer) 10/2021
1	Osteoarthritis 09/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Progressive Multifocal Leukoencephalopathy 10/2020
1	Calcinosis 10/2020
1	Headache (Headaches) 10/2020
1	Sjogren's Syndrome (Sjogren Syndrome) 10/2020
1	COVID-19 03/2020
1	Severe Acute Respiratory Syndrome 03/2020
1	Pneumonia (Pneumonitis) 03/2020
1	Crohn Disease (Crohn's Disease) 01/2020
1	Pericarditis 01/2020
1	Pulmonary Arterial Hypertension 01/2020
1	Autonomic Nervous System Diseases (Dysautonomia) 01/2020
1	Heart Block 01/2020
1	Obesity 01/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 09/2019

Drug/Important Bio-Agent (IBA)

19	AutoantibodiesIBA 10/2020 - 04/2002
11	AntibodiesIBA 11/2020 - 04/2007
8	AntigensIBA 10/2020 - 06/2004
6	Interleukin-10 (Interleukin 10)IBA 01/2023 - 01/2017
6	CytokinesIBA 01/2022 - 04/2002
5	Interleukin-17 (Interleukin 17)IBA 01/2020 - 01/2017
4	EpitopesIBA 10/2021 - 01/2017
4	CollagenIBA 01/2018 - 08/2015
3	Anti-Citrullinated Protein AntibodiesIBA 09/2021 - 04/2007
3	Biomarkers (Surrogate Marker)IBA 09/2021 - 06/2017
3	cyclic citrullinated peptideIBA 09/2021 - 04/2007
3	EnzymesIBA 09/2021 - 04/2007
3	Methotrexate (Mexate)FDA LinkGeneric 10/2020 - 10/2010
3	InterleukinsIBA 01/2020 - 02/2016
3	apremilastIBA 12/2019 - 01/2017
3	Peptides (Polypeptides)IBA 07/2018 - 11/2014
3	acetyl 4-aminosalicylic acidIBA 07/2018 - 11/2014
3	p38 Mitogen-Activated Protein KinasesIBA 01/2014 - 01/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2016
2	trioctyl phosphine oxide (TOPO)IBA 01/2023 - 11/2017
2	Proteins (Proteins, Gene)FDA Link 09/2022 - 11/2014
2	ImmunosorbentsIBA 09/2021 - 04/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 04/2018
2	ametantrone (HAQ)IBA 01/2021 - 01/2020
2	AutoantigensIBA 11/2020 - 11/2014
2	Immunosuppressive Agents (Immunosuppressants)IBA 10/2020 - 07/2018
2	CurcuminIBA 01/2020 - 07/2018
2	Janus Kinase InhibitorsIBA 01/2019 - 12/2017
2	FlavonoidsIBA 03/2018 - 01/2018
2	Tuberculin (PPD)IBA 03/2018 - 10/2010
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2017 - 11/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2010 - 11/2008
2	Interleukin-4 (Interleukin 4)IBA 12/2006 - 03/2005
2	Transforming Growth Factor beta (TGF-beta)IBA 12/2006 - 03/2005
2	Platelet-Derived Growth FactorIBA 12/2006 - 03/2005
1	anti-scl-70 autoantibodiesIBA 03/2024
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023
1	ibrutinibIBA 01/2023
1	Testosterone (Sustanon)FDA Link 09/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2022
1	Antirheumatic Agents (DMARD)IBA 09/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2022
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 07/2022
1	delphinidinIBA 01/2022
1	RibonucleoproteinsIBA 09/2021
1	major vault proteinIBA 09/2021
1	C-Reactive ProteinIBA 09/2021
1	Staphylococcal Protein A (Protein A)IBA 09/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	Minocycline (Cyclops)FDA LinkGeneric 01/2021
1	TetracyclinesIBA 01/2021
1	insulin receptor-related receptor (IRR)IBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 03/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 03/2020
1	InterferonsIBA 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2019
1	Ligases (Synthetase)IBA 09/2019
1	Transfer RNA (tRNA)IBA 09/2019

Therapy/Procedure

2	Therapeutics 04/2018 - 12/2006
1	Drug Therapy (Chemotherapy) 09/2022